Immunotherapies have reshaped cancer treatment across multiple tumor types and are now integral to modern oncology practice. Among them, immune checkpoint inhibitors have emerged as a major therapeutic advance across solid and hematologic malignancies. A clear understanding of their mechanism of action is essential for their appropriate clinical use. Here is a quick question to refresh your knowledge of immune checkpoint inhibitors.
(Scroll down to answer the question) References : Biomedicines & Open Life Sciences ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no explicit or implied warranties about the information's suitability, reliability, or adequacy, including data visualization elements and graphics. We do not endorse any medical treatment, product, ideas, or service, including content…
